Bernhard Kepplinger

Bernhard Kepplinger is a researcher affiliated with Newcastle University, focusing on antibiotic resistance and bacterial infection mechanisms. His work spans microbiology, natural product chemistry, and antimicrobial drug discovery, often involving collaborations with interdisciplinary teams.

Research Interests

His research centers on:

• Elucidating bacterial cell wall biosynthesis perturbations that trigger lysis
• Characterizing natural product antibiotics (e.g., tatiomicin, vancoresmycin)
• Whole-genome sequencing of actinomycetoma pathogens
• Developing therapies for rifampicin-resistant infections
• Optimizing production of cytotoxic ansamycin polyketides